Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ischemic Heart Disease

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 310 articles:
HTML format



Single Articles


    July 2021
  1. JENKINS DJA, Dehghan M, Yusuf S
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality. Reply.
    N Engl J Med. 2021;385:379-380.
    PubMed    


  2. KANTER M, Angadi S, Slavin J
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
    N Engl J Med. 2021;385:378-379.
    PubMed    


  3. LEOW MK, Henry CJ
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
    N Engl J Med. 2021;385:378.
    PubMed    


  4. VARELA DL, Jones TL
    Perivalvular Abscess Causing Coronary-Artery Compression.
    N Engl J Med. 2021;385:e3.
    PubMed    


    June 2021
  5. GERSTEIN HC, Sattar N, Rosenstock J, Ramasundarahettige C, et al
    Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
    N Engl J Med. 2021 Jun 28. doi: 10.1056/NEJMoa2108269.
    PubMed     Abstract available


  6. LAU ES, Scirica B, Schaefer IM, Miller AL, et al
    Hypertensive Heartbreak.
    N Engl J Med. 2021;384:2145-2152.
    PubMed    


    May 2021
  7. LOFFI M, Danzi GB
    Isolated Coronary Artery.
    N Engl J Med. 2021;384:e79.
    PubMed    


  8. BLANCO-DOMINGUEZ R, Sanchez-Diaz R, de la Fuente H, Jimenez-Borreguero LJ, et al
    A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
    N Engl J Med. 2021;384:2014-2027.
    PubMed     Abstract available


  9. YEKU OO, Medford AJ, Fenves AZ, Uljon SN, et al
    Case 15-2021: A 76-Year-Old Woman with Nausea, Diarrhea, and Acute Kidney Failure.
    N Engl J Med. 2021;384:1943-1950.
    PubMed    


  10. PUYMIRAT E, Cayla G, Simon T, Steg PG, et al
    Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction.
    N Engl J Med. 2021 May 16. doi: 10.1056/NEJMoa2104650.
    PubMed     Abstract available


  11. JONES WS, Mulder H, Wruck LM, Pencina MJ, et al
    Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.
    N Engl J Med. 2021 May 15. doi: 10.1056/NEJMoa2102137.
    PubMed     Abstract available


  12. RODRIGUEZ F, Harrington RA
    Antithrombotic Therapy after Acute Coronary Syndromes. Reply.
    N Engl J Med. 2021;384:1873-1874.
    PubMed    


  13. PARADA BARCIA J, Raposeiras Roubin S, Abu-Assi E
    Antithrombotic Therapy after Acute Coronary Syndromes.
    N Engl J Med. 2021;384:1873.
    PubMed    


  14. BITTL JA
    Antithrombotic Therapy after Acute Coronary Syndromes.
    N Engl J Med. 2021;384:1872-1873.
    PubMed    


  15. KONIG MF, Sathiyakumar V, Phan CM, Schulman SP, et al
    Inside and Out.
    N Engl J Med. 2021;384:1753-1760.
    PubMed    


    April 2021
  16. YUSUF S, Joseph P, Pais P
    Polypill in Persons without Cardiovascular Disease. Reply.
    N Engl J Med. 2021;384:1676-1677.
    PubMed    


  17. CAINZOS-ACHIRICA M
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1675-1676.
    PubMed    


  18. WALD N, Wald D, Law M
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1675.
    PubMed    


  19. MESSERLI FH, Brguljan J, Bangalore S
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1674-1675.
    PubMed    


  20. ALAM A, Carey SA, Hall SA
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1674.
    PubMed    


  21. GALLIENI M, Paik JM, Fiorina P
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1673-1674.
    PubMed    


  22. BHATT DL, Steg PG, Pitt B
    Cardiovascular Outcomes with Sotagliflozin. Reply.
    N Engl J Med. 2021;384:1471-1473.
    PubMed    


  23. MARCHAND L, Villar E, Green L
    Cardiovascular Outcomes with Sotagliflozin.
    N Engl J Med. 2021;384:1471.
    PubMed    


  24. BAGLIONI P
    Cardiovascular Outcomes with Sotagliflozin.
    N Engl J Med. 2021;384:1470-1471.
    PubMed    


  25. KALYANI RR
    Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
    N Engl J Med. 2021;384:1248-1260.
    PubMed    


    March 2021
  26. KIM ESH
    Spontaneous Coronary-Artery Dissection. Reply.
    N Engl J Med. 2021;384:1077-1078.
    PubMed    


  27. WANG X, Ge J
    Spontaneous Coronary-Artery Dissection.
    N Engl J Med. 2021;384:1077.
    PubMed    


  28. CAMPOCHIARO C, Tomelleri A, Dagna L
    Spontaneous Coronary-Artery Dissection.
    N Engl J Med. 2021;384:1077.
    PubMed    


  29. GIBBONS GH, Seidman CE, Topol EJ
    Conquering Atherosclerotic Cardiovascular Disease - 50 Years of Progress.
    N Engl J Med. 2021;384:785-788.
    PubMed    


    February 2021
  30. FIOLET ATL, Cornel JH, Thompson PL
    Colchicine in Patients with Chronic Coronary Disease. Reply.
    N Engl J Med. 2021;384:778-779.
    PubMed    


  31. D'AMARIO D, Rodolico D, Galli M
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:778.
    PubMed    


  32. LUCIJANIC M, Javor E, Skelin M
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:777-778.
    PubMed    


  33. FISCHER BG
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:777.
    PubMed    


  34. GEBHARD C, Regitz-Zagrosek V
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:776-777.
    PubMed    


  35. KAISER D, Jackson CD
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:776.
    PubMed    


  36. JENKINS DJA, Dehghan M, Mente A, Bangdiwala SI, et al
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
    N Engl J Med. 2021 Feb 24. doi: 10.1056/NEJMoa2007123.
    PubMed     Abstract available


  37. RODRIGUEZ F, Harrington RA
    Management of Antithrombotic Therapy after Acute Coronary Syndromes.
    N Engl J Med. 2021;384:452-460.
    PubMed    


    January 2021
  38. HUFFMAN MD, Patel A
    Polypills - A Central Strategy for Improving Cardiovascular Health.
    N Engl J Med. 2021;384:288-289.
    PubMed    


  39. SCOTT NS, Thomas SS, DeFaria Yeh D, Fox AS, et al
    Case 2-2021: A 26-Year-Old Pregnant Woman with Ventricular Tachycardia and Shock.
    N Engl J Med. 2021;384:272-282.
    PubMed    


    December 2020
  40. KIM ESH
    Spontaneous Coronary-Artery Dissection.
    N Engl J Med. 2020;383:2358-2370.
    PubMed    


    November 2020
  41. YUSUF S, Joseph P, Dans A, Gao P, et al
    Polypill with or without Aspirin in Persons without Cardiovascular Disease.
    N Engl J Med. 2020 Nov 13. doi: 10.1056/NEJMoa2028220.
    PubMed     Abstract available


    October 2020
  42. LEE TH
    Seizing the Teachable Moment - Lessons from Eisenhower's Heart Attack.
    N Engl J Med. 2020;383:e100.
    PubMed    


  43. O'GARA PT, Mack MJ
    Secondary Mitral Regurgitation.
    N Engl J Med. 2020;383:1458-1467.
    PubMed    


    September 2020
  44. CANNON CP, Pratley R, Dagogo-Jack S, Mancuso J, et al
    Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
    N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMoa2004967.
    PubMed     Abstract available


  45. BANGALORE S, Maron DJ, Hochman JS
    Management of Coronary Disease in Patients with Advanced Kidney Disease. Reply.
    N Engl J Med. 2020;383:1091-1092.
    PubMed    


  46. YING T, Gill JS, Chadban S
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020;383:1091.
    PubMed    


  47. AFSAR B, Elsurer Afsar R, Kanbay M
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020;383:1090-1091.
    PubMed    


  48. SHETTY HB, Shetty AH
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020;383:1090.
    PubMed    


  49. WEBSTER MWI, Stewart RAH
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020;383:1090.
    PubMed    


  50. LEGRAND M, Rossignol P
    Cardiovascular Consequences of Acute Kidney Injury. Reply.
    N Engl J Med. 2020;383:1094.
    PubMed    


  51. CHALIKIAS G, Tziakas D
    Cardiovascular Consequences of Acute Kidney Injury.
    N Engl J Med. 2020;383:1094.
    PubMed    


  52. BURTSCHER J, Millet GP, Burtscher M
    Cardiovascular Consequences of Acute Kidney Injury.
    N Engl J Med. 2020;383:1093.
    PubMed    


  53. ANTMAN EM, Braunwald E
    Invasive or Conservative Strategy for Stable Coronary Disease. Reply.
    N Engl J Med. 2020;383:e66.
    PubMed    


  54. MARON DJ, Hochman JS
    Invasive or Conservative Strategy for Stable Coronary Disease. Reply.
    N Engl J Med. 2020;383:e66.
    PubMed    


  55. KARIMI GALOUGAHI K, Patel S, Adams M
    Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020;383:e66.
    PubMed    


  56. VAN 'T HOF A, Crea F
    Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020;383:e66.
    PubMed    


  57. VAN MIEGHEM NM, Daemen J, Zijlstra F
    Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020;383:e66.
    PubMed    


  58. TOMODA H
    Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020;383:e66.
    PubMed    


  59. DANGAS G, Roumeliotis A, Giustino G
    Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020;383:e66.
    PubMed    


    August 2020
  60. NIDORF SM, Fiolet ATL, Mosterd A, Eikelboom JW, et al
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2020 Aug 31. doi: 10.1056/NEJMoa2021372.
    PubMed     Abstract available


  61. PACKER M, Anker SD, Butler J, Filippatos G, et al
    Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2022190.
    PubMed     Abstract available


  62. KIRCHHOF P, Camm AJ, Goette A, Brandes A, et al
    Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2019422.
    PubMed     Abstract available


  63. SCOTT AC, McDonald A, Roberts T, Martin C, et al
    Cardiovascular Telemedicine Program in Rural Australia.
    N Engl J Med. 2020;383:883-884.
    PubMed    


  64. VERGALLO R, Crea F
    Atherosclerotic Plaque Healing.
    N Engl J Med. 2020;383:846-857.
    PubMed    


  65. FERENCE BA, Ray KK, Nicholls SJ
    Mendelian Randomization Study of ACLY and Cardiovascular Disease. Reply.
    N Engl J Med. 2020;383:e50.
    PubMed    


  66. HOLM H, Sulem P, Helgadottir A, Tragante V, et al
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2020;383:e50.
    PubMed    


  67. DAMASK A, Paulding C, Baras A, Carey D, et al
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2020;383:e50.
    PubMed    


  68. KLARIN D, O'Donnell CJ, Kathiresan S
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2020;383:e50.
    PubMed    


    July 2020
  69. STONE GW, Serruys PW, Sabik JF
    PCI or CABG for Left Main Coronary Artery Disease. Reply.
    N Engl J Med. 2020;383:292-294.
    PubMed    


  70. BAKAEEN FG, Svennson LG
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:292.
    PubMed    


  71. KAPOOR S, Mulukutla S
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:291-292.
    PubMed    


  72. LOPEZ-AYALA P, Koechlin L, Mueller C
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:291.
    PubMed    


  73. LOZANO I, Rondan J, Vegas JM
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:290-291.
    PubMed    


  74. TAGGART DP, Gaudino M
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:290.
    PubMed    


  75. NEWTON-CHEH C, Zlotoff DA, Hung J, Rupasov A, et al
    Case 24-2020: A 44-Year-Old Woman with Chest Pain, Dyspnea, and Shock.
    N Engl J Med. 2020 Jul 15. doi: 10.1056/NEJMcpc2004975.
    PubMed    


    June 2020
  76. LEGRAND M, Rossignol P
    Cardiovascular Consequences of Acute Kidney Injury.
    N Engl J Med. 2020;382:2238-2247.
    PubMed    


  77. MEHRA MR, Desai SS, Kuy S, Henry TD, et al
    Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
    N Engl J Med. 2020 Jun 4. doi: 10.1056/NEJMc2021225.
    PubMed    


  78. RUBIN EJ
    Expression of Concern: Mehra MR et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
    N Engl J Med. 2020 Jun 2. doi: 10.1056/NEJMe2020822.
    PubMed    


    May 2020
  79. HIGANO CS
    Cardiovascular Disease and Androgen Axis-Targeted Drugs for Prostate Cancer.
    N Engl J Med. 2020 May 29. doi: 10.1056/NEJMe2016433.
    PubMed    


  80. TSIMIKAS S, Karwatowska-Prokopczuk E, Xia S
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. Reply.
    N Engl J Med. 2020;382:e65.
    PubMed    


  81. FERRO CJ, Sarafidis P, Ortiz A
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020;382:e65.
    PubMed    


  82. ANDREOTTI F, Maggioni AP
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020;382:e65.
    PubMed    


  83. ALKHALIL M
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020;382:e65.
    PubMed    


  84. SOLOMON MD, McNulty EJ, Rana JS, Leong TK, et al
    The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction.
    N Engl J Med. 2020 May 19. doi: 10.1056/NEJMc2015630.
    PubMed    


  85. MEHRA MR, Desai SS, Kuy S, Henry TD, et al
    Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.
    N Engl J Med. 2020 May 1. doi: 10.1056/NEJMoa2007621.
    PubMed     Abstract available


    April 2020
  86. DE FILIPPO O, D'Ascenzo F, Angelini F, Bocchino PP, et al
    Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy.
    N Engl J Med. 2020 Apr 28. doi: 10.1056/NEJMc2009166.
    PubMed    


  87. TARDIF JC, L'Allier PL, Guertin MC
    Low-Dose Colchicine after Myocardial Infarction. Reply.
    N Engl J Med. 2020;382:1668.
    PubMed    


  88. CHIARITO M, Condorelli G, Stefanini GG
    Low-Dose Colchicine after Myocardial Infarction.
    N Engl J Med. 2020;382:1667-1668.
    PubMed    


  89. REINDL M, Metzler B, Reinstadler SJ
    Low-Dose Colchicine after Myocardial Infarction.
    N Engl J Med. 2020;382:1667.
    PubMed    


  90. FURER V, Elkayam O, Caspi D
    Low-Dose Colchicine after Myocardial Infarction.
    N Engl J Med. 2020;382:1666-1667.
    PubMed    


  91. KITTLESON MM
    The Invisible Hand - Medical Care during the Pandemic.
    N Engl J Med. 2020;382:1586-1587.
    PubMed    


  92. SPERTUS JA, Jones PG, Maron DJ, Mark DB, et al
    Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease.
    N Engl J Med. 2020;382:1619-1628.
    PubMed     Abstract available


  93. BANGALORE S, Sharma A, Slotwiner A, Yatskar L, et al
    ST-Segment Elevation in Patients with Covid-19 - A Case Series.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2009020.
    PubMed    


  94. MEHTA SR, Wood DA, Cairns JA
    Complete Revascularization with Multivessel PCI for Myocardial Infarction. Reply.
    N Engl J Med. 2020;382:1571-1572.
    PubMed    


  95. DOENST T, Boning A, Thiele H
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1571.
    PubMed    


  96. FERREIRA RM, Salis LHA, de Souza E Silva NA
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1570.
    PubMed    


  97. BURGESS SN, Juergens CP, French JK
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1569-1570.
    PubMed    


  98. DESCHNER M, Glanz A
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1569.
    PubMed    


  99. AUER J, Berent R, Gurtner F
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1569.
    PubMed    


  100. BOGATY P, Brophy JM
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1568.
    PubMed    


  101. RAY KK, Wright RS, Kallend D, Koenig W, et al
    Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
    N Engl J Med. 2020;382:1507-1519.
    PubMed     Abstract available


    March 2020
  102. BANGALORE S, Maron DJ, O'Brien SM, Fleg JL, et al
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa1915925.
    PubMed     Abstract available


  103. MARON DJ, Hochman JS, Reynolds HR, Bangalore S, et al
    Initial Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa1915922.
    PubMed     Abstract available


  104. SPERTUS JA, Jones PG, Maron DJ, O'Brien SM, et al
    Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa1916370.
    PubMed     Abstract available


  105. ANTMAN EM, Braunwald E
    Managing Stable Ischemic Heart Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMe2000239.
    PubMed    


  106. WINDECKER S, Latib A, Kedhi E, Kirtane AJ, et al
    Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
    N Engl J Med. 2020;382:1208-1218.
    PubMed     Abstract available



  107. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
    N Engl J Med. 2020;382:1078.
    PubMed    


  108. BOHOSSIAN HB, Lopes EW, Roller LA, Ananthakrishnan AN, et al
    Case 8-2020: An 89-Year-Old Man with Recurrent Abdominal Pain and Bloody Stools.
    N Engl J Med. 2020;382:1042-1052.
    PubMed    


    February 2020
  109. OLENSKI AR, Zimerman A, Coussens S, Jena AB, et al
    Behavioral Heuristics in Coronary-Artery Bypass Graft Surgery.
    N Engl J Med. 2020;382:778-779.
    PubMed    


    January 2020
  110. SCHUPKE S, Kastrati A
    Ticagrelor or Prasugrel in Acute Coronary Syndromes. Reply.
    N Engl J Med. 2020;382:487.
    PubMed    


  111. SHARMA S, Lardizabal J, Sharma R
    Ticagrelor or Prasugrel in Acute Coronary Syndromes.
    N Engl J Med. 2020;382:487.
    PubMed    


  112. CARBONELL-PRAT B, Flores-Umanzor E, Brugaletta S
    Ticagrelor or Prasugrel in Acute Coronary Syndromes.
    N Engl J Med. 2020;382:486.
    PubMed    


  113. WANG TJ, Munoz D, Blot WJ
    Polypill for Cardiovascular Disease Prevention in an Underserved Population. Reply.
    N Engl J Med. 2020;382:95.
    PubMed    


  114. BILAL U, Cainzos-Achirica M
    Polypill for Cardiovascular Disease Prevention in an Underserved Population.
    N Engl J Med. 2020;382:94-95.
    PubMed    


  115. BRUGTS JJ
    Polypill for Cardiovascular Disease Prevention in an Underserved Population.
    N Engl J Med. 2020;382:94.
    PubMed    


  116. TSIMIKAS S, Karwatowska-Prokopczuk E, Gouni-Berthold I, Tardif JC, et al
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020 Jan 1. doi: 10.1056/NEJMoa1905239.
    PubMed     Abstract available


    December 2019
  117. NEUMANN JT, Twerenbold R, Blankenberg S
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction. Reply.
    N Engl J Med. 2019;381:2483.
    PubMed    


  118. AKSOY A, Agirbasli M
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
    N Engl J Med. 2019;381:2482-2483.
    PubMed    


  119. LAU CS, Aw TC
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
    N Engl J Med. 2019;381:2482.
    PubMed    


  120. YASUDA S, Ogawa H
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. Reply.
    N Engl J Med. 2019;381:2481.
    PubMed    


  121. GREMMEL T
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019;381:2480-2481.
    PubMed    


  122. PATTI G, De Caterina R
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019;381:2480.
    PubMed    


  123. MARQUIS-GRAVEL G, Roe MT
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019;381:2479-2480.
    PubMed    


  124. PANZA JA, Velazquez EJ, Bonow RO
    Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. Reply.
    N Engl J Med. 2019;381:2374.
    PubMed    


  125. SHARMA S, Sharma R, Lardizabal J
    Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
    N Engl J Med. 2019;381:2373.
    PubMed    


  126. NAPP LC, Bengel FM, Bauersachs J
    Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
    N Engl J Med. 2019;381:2373.
    PubMed    


  127. NAGEL E, Berry C
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. Reply.
    N Engl J Med. 2019;381:2277-2278.
    PubMed    


  128. TEBALDI M, Biscaglia S, Campo G
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
    N Engl J Med. 2019;381:2277.
    PubMed    


  129. DESCHNER M, Glanz A
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
    N Engl J Med. 2019;381:2276-2277.
    PubMed    


  130. O'ROURKE MF, Adji A
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
    N Engl J Med. 2019;381:2276.
    PubMed    


    November 2019
  131. HUSAIN M, Donsmark M, Bain SC
    Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. Reply.
    N Engl J Med. 2019;381:2076-2077.
    PubMed    


  132. ZWECK E, Westenfeld R, Szendroedi J
    Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2019;381:2075-2076.
    PubMed    


  133. MEHRAN R, Baber U, Sharma SK, Cohen DJ, et al
    Ticagrelor with or without Aspirin in High-Risk Patients after PCI.
    N Engl J Med. 2019;381:2032-2042.
    PubMed     Abstract available


  134. TARDIF JC, Kouz S, Waters DD, Bertrand OF, et al
    Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
    N Engl J Med. 2019 Nov 16. doi: 10.1056/NEJMoa1912388.
    PubMed     Abstract available


  135. NEWBY LK
    Inflammation as a Treatment Target after Acute Myocardial Infarction.
    N Engl J Med. 2019 Nov 16. doi: 10.1056/NEJMe1914378.
    PubMed    


    October 2019

  136. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
    N Engl J Med. 2019;381:1789.
    PubMed    


  137. BRIOSA E GALA A, Rawlins J
    Posterior-Wall Myocardial Infarction.
    N Engl J Med. 2019;381:e32.
    PubMed    


  138. FLINT AC, Conell C, Bhatt DL
    Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes. Reply.
    N Engl J Med. 2019;381:1692-1693.
    PubMed    


  139. VERDECCHIA P, Angeli F, Reboldi G
    Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes.
    N Engl J Med. 2019;381:1691-1692.
    PubMed    


  140. QUINN S, McEvoy JW
    Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes.
    N Engl J Med. 2019;381:1690-1691.
    PubMed    


  141. KOSTIS WJ, Kostis JB, Moreyra AE
    Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes.
    N Engl J Med. 2019;381:1690.
    PubMed    


  142. BERNSTEIN SN, Cudemus-Deseda GA, Ortiz VE, Goodman A, et al
    Case 33-2019: A 35-Year-Old Woman with Cardiopulmonary Arrest during Cesarean Section.
    N Engl J Med. 2019;381:1664-1673.
    PubMed    


  143. CLAASSENS DMF, Vos GJA, Bergmeijer TO, Hermanides RS, et al
    A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.
    N Engl J Med. 2019;381:1621-1631.
    PubMed     Abstract available


  144. JNEID H
    Ticagrelor or Prasugrel in Acute Coronary Syndromes - The Winner Takes It All?
    N Engl J Med. 2019;381:1582-1585.
    PubMed    


  145. MICHOS ED, McEvoy JW, Blumenthal RS
    Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease.
    N Engl J Med. 2019;381:1557-1567.
    PubMed    


  146. KOBER L, Engstrom T
    A More COMPLETE Picture of Revascularization in STEMI.
    N Engl J Med. 2019;381:1472-1474.
    PubMed    


    September 2019
  147. STONE GW, Kappetein AP, Sabik JF, Pocock SJ, et al
    Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
    N Engl J Med. 2019 Sep 28. doi: 10.1056/NEJMoa1909406.
    PubMed     Abstract available


  148. MUNOZ D, Uzoije P, Reynolds C, Miller R, et al
    Polypill for Cardiovascular Disease Prevention in an Underserved Population.
    N Engl J Med. 2019;381:1114-1123.
    PubMed     Abstract available


  149. YASUDA S, Kaikita K, Akao M, Ako J, et al
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019 Sep 2. doi: 10.1056/NEJMoa1904143.
    PubMed     Abstract available


  150. BECKER RC
    Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease.
    N Engl J Med. 2019 Sep 2. doi: 10.1056/NEJMe1910560.
    PubMed    


  151. STEG PG, Bhatt DL, Simon T, Fox K, et al
    Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1908077.
    PubMed     Abstract available


  152. BATES ER
    Antiplatelet Therapy in Patients with Coronary Disease and Type 2 Diabetes.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMe1910813.
    PubMed    


  153. MEHTA SR, Wood DA, Storey RF, Mehran R, et al
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1907775.
    PubMed     Abstract available


  154. SCHUPKE S, Neumann FJ, Menichelli M, Mayer K, et al
    Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1908973.
    PubMed     Abstract available


    August 2019
  155. PANZA JA, Ellis AM, Al-Khalidi HR, Holly TA, et al
    Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
    N Engl J Med. 2019;381:739-748.
    PubMed     Abstract available


    July 2019
  156. HARDIN CC, Malhotra R, Petranovic M, Klassen S, et al
    Case 23-2019: A 52-Year-Old Man with Fever, Cough, and Hypoxemia.
    N Engl J Med. 2019;381:359-369.
    PubMed    


  157. FLINT AC, Conell C, Ren X, Banki NM, et al
    Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes.
    N Engl J Med. 2019;381:243-251.
    PubMed     Abstract available


  158. LEMKES JS, Janssens GN, van Royen N
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation. Reply.
    N Engl J Med. 2019;381:189-190.
    PubMed    


  159. DE SILVA K, Perera D
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:189.
    PubMed    


  160. KIM YJ, Kim WY
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:189.
    PubMed    


  161. WALDMANN V, Bonnet G, Spaulding C
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:188-189.
    PubMed    


  162. DEGRELL P, Varenne O
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:188.
    PubMed    


    June 2019
  163. NEUMANN JT, Twerenbold R, Ojeda F, Sorensen NA, et al
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
    N Engl J Med. 2019;380:2529-2540.
    PubMed     Abstract available


  164. NAGEL E, Greenwood JP, McCann GP, Bettencourt N, et al
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
    N Engl J Med. 2019;380:2418-2428.
    PubMed     Abstract available


  165. HUSAIN M, Birkenfeld AL, Donsmark M, Dungan K, et al
    Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2019 Jun 11. doi: 10.1056/NEJMoa1901118.
    PubMed     Abstract available


  166. RIDKER PM
    Methotrexate for Prevention of Cardiovascular Events. Reply.
    N Engl J Med. 2019;380:2277.
    PubMed    


  167. HUANG Y, Chan AW, Shear NH
    Methotrexate for Prevention of Cardiovascular Events.
    N Engl J Med. 2019;380:2277.
    PubMed    


  168. VAN VOLLENHOVEN RF, Nurmohamed M
    Methotrexate for Prevention of Cardiovascular Events.
    N Engl J Med. 2019;380:2276-2277.
    PubMed    


    May 2019
  169. DE LA FUENTE J, Bird J
    Coronary Arteritis in IgG4-Related Disease.
    N Engl J Med. 2019;380:2156.
    PubMed    


  170. YU D, Blair JEA
    A STEMI Mimic.
    N Engl J Med. 2019;380:e41.
    PubMed    


  171. SCHWARTZ GG, Steg PG, Szarek M
    Alirocumab after Acute Coronary Syndrome. Reply.
    N Engl J Med. 2019;380:2077.
    PubMed    


  172. PIGNATELLI P, Camera M, Violi F
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2076.
    PubMed    


  173. ENNEZAT PV, Hansen MR
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2076.
    PubMed    


  174. LAN NSR, Yeap BB, Fegan PG
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2075-2076.
    PubMed    


  175. ALKHALIL M
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2075.
    PubMed    


  176. GAO Y, Hou B
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2074-2075.
    PubMed    


  177. THIELE H, Schneider S, Desch S
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock. Reply.
    N Engl J Med. 2019;380:1877.
    PubMed    


  178. YAN F, Thall P, Yuan Y
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
    N Engl J Med. 2019;380:1876-1877.
    PubMed    


  179. WIVIOTT SD, Raz I, Sabatine MS
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. Reply.
    N Engl J Med. 2019;380:1881-1882.
    PubMed    


  180. AKINCI B
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2019;380:1881.
    PubMed    


  181. BAGLIONI P
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2019;380:1880-1881.
    PubMed    


    April 2019
  182. BHATT DL, Steg PG, Miller M
    Cardiovascular Risk Reduction with Icosapent Ethyl. Reply.
    N Engl J Med. 2019;380:1678.
    PubMed    


  183. BORGHI C, Fogacci F, Cicero AFG
    Cardiovascular Risk Reduction with Icosapent Ethyl.
    N Engl J Med. 2019;380:1678.
    PubMed    


  184. CHAN LN
    Cardiovascular Risk Reduction with Icosapent Ethyl.
    N Engl J Med. 2019;380:1677.
    PubMed    


  185. MUSHER DM, Abers MS, Corrales-Medina VF
    Acute Infection and Myocardial Infarction. Reply.
    N Engl J Med. 2019;380.
    PubMed    


  186. FRANK RC, Hanidziar D
    Acute Infection and Myocardial Infarction.
    N Engl J Med. 2019;380.
    PubMed    


    March 2019
  187. LANDONI G, Lomivorotov VV, Nigro Neto C, Monaco F, et al
    Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery.
    N Engl J Med. 2019 Mar 19. doi: 10.1056/NEJMoa1816476.
    PubMed     Abstract available


  188. LEMKES JS, Janssens GN, van der Hoeven NW, Jewbali LSD, et al
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019 Mar 18. doi: 10.1056/NEJMoa1816897.
    PubMed     Abstract available


  189. ABELLA BS, Gaieski DF
    Coronary Angiography after Cardiac Arrest - The Right Timing or the Right Patients?
    N Engl J Med. 2019 Mar 18. doi: 10.1056/NEJMe1901651.
    PubMed    


  190. LOPES RD, Heizer G, Aronson R, Vora AN, et al
    Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMoa1817083.
    PubMed     Abstract available


  191. MEHTA SR
    Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndromes or PCI.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMe1902214.
    PubMed    


  192. FERENCE BA, Ray KK, Catapano AL, Ference TB, et al
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2019;380:1033-1042.
    PubMed     Abstract available


  193. OH J, Kang SM
    Rivaroxaban in Patients with Heart Failure.
    N Engl J Med. 2019;380:988.
    PubMed    


    February 2019
  194. RIDKER PM, Everett BM, Pradhan A, MacFadyen JG, et al
    Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
    N Engl J Med. 2019;380:752-762.
    PubMed     Abstract available


  195. FAUCHIER L, Clementy N, Bisson A
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2019;380:600.
    PubMed    


  196. STECKER EC, Walsh MN
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2019;380:599.
    PubMed    



  197. Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2019;380:599-601.
    PubMed    


    January 2019
  198. TAGGART DP, Benedetto U, Gerry S, Altman DG, et al
    Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years.
    N Engl J Med. 2019;380:437-446.
    PubMed     Abstract available



  199. Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298-300.
    PubMed    


  200. CHEUNG BMY
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:299-300.
    PubMed    


  201. SANDHU AT, Maron DJ
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:299.
    PubMed    


  202. BOGATY P, Brophy J
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298-9.
    PubMed    


  203. KOROSOGLOU G, Giusca S
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298.
    PubMed    


  204. MUSHER DM, Abers MS, Corrales-Medina VF
    Acute Infection and Myocardial Infarction.
    N Engl J Med. 2019;380:171-176.
    PubMed    


  205. VERMA S, Mazer CD
    Open or Endoscopic Vein Harvesting for Coronary-Artery Bypass Grafting.
    N Engl J Med. 2019;380:189-191.
    PubMed    


    December 2018
  206. MATSUURA H, Ohya M
    Coronary-Artery Occlusion from Kawasaki's Disease.
    N Engl J Med. 2018;379:e42.
    PubMed    


  207. WADHERA RK, Bhatt DL
    Toward Precision Policy - The Case of Cardiovascular Care.
    N Engl J Med. 2018;379:2193-2195.
    PubMed    


    November 2018
  208. BURNETT JR, Hooper AJ
    PCSK9 - A Journey to Cardiovascular Outcomes.
    N Engl J Med. 2018;379:2161-2162.
    PubMed    


  209. KOPJAR T, Gasparovic H, Biocina B
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966-7.
    PubMed    


  210. REHMAN SM, Duggan SMJ
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966.
    PubMed    


  211. ALSAGHEIR A, Belley-Cote EP, Whitlock RP
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966.
    PubMed    



  212. Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966-1968.
    PubMed    


  213. ZENATI MA, Bhatt DL, Bakaeen FG, Stock EM, et al
    Randomized Trial of Endoscopic or Open Vein-Graft Harvesting for Coronary-Artery Bypass.
    N Engl J Med. 2018 Nov 11. doi: 10.1056/NEJMoa1812390.
    PubMed     Abstract available


  214. MANSON JE, Cook NR, Lee IM, Christen W, et al
    Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1811403.
    PubMed     Abstract available


  215. MANSON JE, Cook NR, Lee IM, Christen W, et al
    Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1809944.
    PubMed     Abstract available


  216. BHATT DL, Steg PG, Miller M, Brinton EA, et al
    Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812792.
    PubMed     Abstract available


  217. WIVIOTT SD, Raz I, Bonaca MP, Mosenzon O, et al
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812389.
    PubMed     Abstract available


  218. SCHWARTZ GG, Steg PG, Szarek M, Bhatt DL, et al
    Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
    N Engl J Med. 2018 Nov 7. doi: 10.1056/NEJMoa1801174.
    PubMed     Abstract available


  219. ADRIAENSSENS T, Van de Werf F
    Is Culprit-Lesion-Only PCI in Cardiogenic Shock Still Better at 1 Year?
    N Engl J Med. 2018;379:1775-1776.
    PubMed    


  220. THIELE H, Akin I, Sandri M, de Waha-Thiele S, et al
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
    N Engl J Med. 2018;379:1699-1710.
    PubMed     Abstract available


    October 2018

  221. Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1582-1584.
    PubMed    


  222. MONTENEGRO MF, Lundberg JO, Weitzberg E
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1583-4.
    PubMed    


  223. PEREZ-GOMEZ MV, Bartsch LA, Ortiz A
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1583.
    PubMed    


  224. BHATTACHARYYA S, Macklin EA, Schwarzschild MA
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1582.
    PubMed    


  225. DRAZEN JM
    Expression of Concern: Beltrami AP et al. Evidence That Human Cardiac Myocytes Divide after Myocardial Infarction. N Engl J Med 2001;344:1750-7 and Quaini F et al. Chimerism of the Transplanted Heart. N Engl J Med 2002;346:5-15.
    N Engl J Med. 2018 Oct 17. doi: 10.1056/NEJMe1813801.
    PubMed    



  226. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
    N Engl J Med. 2018;379:1486.
    PubMed    



  227. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387-1389.
    PubMed    


  228. STEWART RAH
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1388.
    PubMed    


  229. JENKINS D, Sievenpiper J, Jones P
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387-8.
    PubMed    


  230. CORREIA LCL
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387.
    PubMed    


    September 2018
  231. FIELD ME, Page RL
    Another Shock for Sudden Death Prevention after Myocardial Infarction.
    N Engl J Med. 2018;379:1274-1275.
    PubMed    


  232. OLGIN JE, Pletcher MJ, Vittinghoff E, Wranicz J, et al
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2018;379:1205-1215.
    PubMed     Abstract available


  233. MCNEIL JJ, Wolfe R, Woods RL, Tonkin AM, et al
    Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
    N Engl J Med. 2018 Sep 16. doi: 10.1056/NEJMoa1805819.
    PubMed     Abstract available


    August 2018
  234. ZANNAD F, Anker SD, Byra WM, Cleland JGF, et al
    Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.
    N Engl J Med. 2018 Aug 27. doi: 10.1056/NEJMoa1808848.
    PubMed     Abstract available


  235. BOHULA EA, Wiviott SD, McGuire DK, Inzucchi SE, et al
    Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808721.
    PubMed     Abstract available


  236. MAZER CD, Whitlock RP, Fergusson DA, Belley-Cote E, et al
    Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808561.
    PubMed     Abstract available



  237. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.
    N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMoa1805971.
    PubMed     Abstract available


  238. HOFFMANN U, Udelson JE
    Imaging Coronary Anatomy and Reducing Myocardial Infarction.
    N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMe1809203.
    PubMed    


  239. RAWSHANI A, Rawshani A, Franzen S, Sattar N, et al
    Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2018;379:633-644.
    PubMed     Abstract available


  240. WEINER RB, Hucker WJ, Meyersohn NM, Dudzinski DM, et al
    Case 25-2018: A 63-Year-Old Man with Syncope.
    N Engl J Med. 2018;379:670-680.
    PubMed    


    July 2018
  241. XAPLANTERIS P, Fournier S, Pijls NHJ, Fearon WF, et al
    Five-Year Outcomes with PCI Guided by Fractional Flow Reserve.
    N Engl J Med. 2018;379:250-259.
    PubMed     Abstract available


    June 2018
  242. CUERVO G, Viasus D, Carratala J
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2540.
    PubMed    


  243. BUCKLEY LF
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539-40.
    PubMed    


  244. CASTILLO-RODRIGUEZ E, Fernandez-Prado R, Ortiz A
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539.
    PubMed    


  245. WIESSMAN M, Shlomai A
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539.
    PubMed    


  246. WAXMAN DA, Kanzaria HK, Schriger DL
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2538-9.
    PubMed    



  247. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2538-2541.
    PubMed    


  248. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
    Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMc1806491.
    PubMed    


  249. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMoa1800389.
    PubMed     Abstract available


  250. ARBOINE L, Palacios JM
    Left Main Coronary Artery Aneurysm.
    N Engl J Med. 2018;378:e32.
    PubMed    


    May 2018
  251. SHAPIRA OM
    Radial Artery as the Preferred Second Conduit for Coronary Bypass.
    N Engl J Med. 2018;378:2134-2135.
    PubMed    


  252. JOHNSTON SC, Easton JD, Farrant M, Barsan W, et al
    Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1800410.
    PubMed     Abstract available


    April 2018
  253. GAUDINO M, Benedetto U, Fremes S, Biondi-Zoccai G, et al
    Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018 Apr 30. doi: 10.1056/NEJMoa1716026.
    PubMed     Abstract available


  254. CAMPBELL BCV, Mitchell PJ, Churilov L, Yassi N, et al
    Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    N Engl J Med. 2018;378:1573-1582.
    PubMed     Abstract available


  255. BAIRD AE
    Paving the Way for Improved Treatment of Acute Stroke with Tenecteplase.
    N Engl J Med. 2018;378:1635-1636.
    PubMed    


  256. ZHAO YT, Huang YS
    ECG Pattern Associated with Left Anterior Descending Coronary Artery Occlusion.
    N Engl J Med. 2018;378:e22.
    PubMed    


  257. AMELOOT K, Daemen J, Van Mieghem N
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1360-1.
    PubMed    


  258. PAPPALARDO F, Bertoldi L
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1360.
    PubMed    


  259. PASCERI V, Pelliccia F, Speciale G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359-60.
    PubMed    


  260. FERREIRA RM, Salis LHA, e Silva NAS
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359.
    PubMed    


  261. FLEISSNER F, Haverich A, Warnecke G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358-9.
    PubMed    


  262. SHARMA S, Lardizabal J
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358.
    PubMed    



  263. PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358-1361.
    PubMed    


    March 2018
  264. LOSCALZO J, Roy N, Shah RV, Tsai JN, et al
    Case 8-2018: A 55-Year-Old Woman with Shock and Labile Blood Pressure.
    N Engl J Med. 2018;378:1043-1053.
    PubMed    


  265. WHITE WB, Saag KG, Becker MA, Borer JS, et al
    Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
    N Engl J Med. 2018 Mar 12. doi: 10.1056/NEJMoa1710895.
    PubMed     Abstract available


  266. LEE F, Maggiore P, Chung K
    Self-Management of an Inferior ST-Segment Elevation Myocardial Infarction.
    N Engl J Med. 2018;378:960-962.
    PubMed    


    February 2018

  267. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2018;378:782.
    PubMed    


    January 2018
  268. FAUCHIER L, Bisson A, Angoulvant D
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395.
    PubMed    


  269. KWONG JC, Schwartz KL, Campitelli MA, Chung H, et al
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:345-353.
    PubMed     Abstract available


  270. CAHILL TJ, Wijesurendra RS, Casadei B
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:397.
    PubMed    


  271. HELFT G, Le Feuvre C, Zaman A
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:397.
    PubMed    


  272. JEONG YH, Bae JS, Gurbel PA
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:396.
    PubMed    


  273. AJANI AE
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395-6.
    PubMed    



  274. Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395-398.
    PubMed    


  275. FAUCHIER L, Bisson A, Angoulvant D
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395.
    PubMed    


  276. WEBSTER MWI, Stables RH
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:299.
    PubMed    


  277. SHAH R
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:299.
    PubMed    


  278. VIJ A, Kodumuri V
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298.
    PubMed    


  279. BULLUCK H
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298.
    PubMed    



  280. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298-301.
    PubMed    


  281. STONE GW
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:300-1.
    PubMed    



  282. Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:200-202.
    PubMed    


  283. LELLOUCHE F, Simon M, L'Her E
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:201.
    PubMed    


  284. SAMADANI U, Affana CK
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:200-1.
    PubMed    


  285. ROSENBAUM L
    Swallowing a Spy - The Potential Uses of Digital Adherence Monitoring.
    N Engl J Med. 2018;378:101-103.
    PubMed    


    December 2017
  286. IMPRIALOS KP, Stavropoulos K, Doumas M
    Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:2502.
    PubMed    


  287. HOLMAN RR, Bethel MA, Hernandez AF
    Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:2502.
    PubMed    


  288. TSIARAS SV, Safi LM, Ghoshhajra BB, Lindsay ME, et al
    Case 39-2017. A 41-Year-Old Woman with Recurrent Chest Pain.
    N Engl J Med. 2017;377:2475-2484.
    PubMed    


  289. KELLY NP, Gerhard-Herman M, Desai AS, Miller AL, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:2267-2272.
    PubMed    


    November 2017

  290. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2097-2099.
    PubMed    


  291. RAJAGOPALAN S, Brook R
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2098-9.
    PubMed    


  292. FERNANDEZBALSELLS MM, Sojo-Vega L, Ricart-Engel W
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2098.
    PubMed    


  293. BAGLIONI P
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2097-8.
    PubMed    


  294. KELLY NP, Vaidya A, Gerhard-Herman M, Desai AS, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:e29.
    PubMed    


  295. MAZER CD, Whitlock RP, Fergusson DA, Hall J, et al
    Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.
    N Engl J Med. 2017 Nov 12. doi: 10.1056/NEJMoa1711818.
    PubMed     Abstract available


  296. JACOB KA, Gianoli M, van Dijk D
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897-8.
    PubMed    


  297. TAGGART DP, Puskas JD
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897.
    PubMed    


  298. JONES SG, Pullan MD, Kirmani BH
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1896-7.
    PubMed    


  299. NOZAWA T, Imagawa T, Ito S
    Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki's Disease.
    N Engl J Med. 2017;377:1894-1896.
    PubMed    



  300. Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1898-1899.
    PubMed    


    October 2017
  301. THIELE H, Akin I, Sandri M, Fuernau G, et al
    PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.
    N Engl J Med. 2017 Oct 30. doi: 10.1056/NEJMoa1710261.
    PubMed     Abstract available


  302. MONTONE RA, Minelli S
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595-6.
    PubMed    


  303. AGGARWAL S, Pavlides G
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595.
    PubMed    


  304. BHATT DL
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1598-1599.
    PubMed    


  305. DAVIES JE, Sen S, Escaned J
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1597-1598.
    PubMed    


  306. PIJLS NHJ, De Bruyne B
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596.
    PubMed    



  307. Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596-7.
    PubMed    


    September 2017
  308. BOWMAN L, Hopewell JC, Chen F, Wallendszus K, et al
    Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
    N Engl J Med. 2017;377:1217-1227.
    PubMed     Abstract available


  309. RIDKER PM, Everett BM, Thuren T, MacFadyen JG, et al
    Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
    N Engl J Med. 2017;377:1119-1131.
    PubMed     Abstract available


  310. HOLMAN RR, Bethel MA, Mentz RJ, Thompson VP, et al
    Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017 Sep 14. doi: 10.1056/NEJMoa1612917.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: